Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Net Cash Flow (2017 - 2025)

Historic Net Cash Flow for Q32 Bio (QTTB) over the last 9 years, with Q3 2025 value amounting to -$5.8 million.

  • Q32 Bio's Net Cash Flow rose 3250.61% to -$5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.0 million, marking a year-over-year decrease of 18372.51%. This contributed to the annual value of $47.3 million for FY2024, which is 35907.2% up from last year.
  • According to the latest figures from Q3 2025, Q32 Bio's Net Cash Flow is -$5.8 million, which was up 3250.61% from -$10.7 million recorded in Q2 2025.
  • Q32 Bio's 5-year Net Cash Flow high stood at $138.1 million for Q1 2022, and its period low was -$133.0 million during Q3 2022.
  • Over the past 5 years, Q32 Bio's median Net Cash Flow value was -$10.7 million (recorded in 2025), while the average stood at -$9.7 million.
  • In the last 5 years, Q32 Bio's Net Cash Flow crashed by 70700.18% in 2022 and then surged by 77989.75% in 2024.
  • Over the past 5 years, Q32 Bio's Net Cash Flow (Quarter) stood at $13.2 million in 2021, then plummeted by 169.35% to -$9.2 million in 2022, then dropped by 15.94% to -$10.6 million in 2023, then dropped by 4.46% to -$11.1 million in 2024, then skyrocketed by 47.87% to -$5.8 million in 2025.
  • Its Net Cash Flow stands at -$5.8 million for Q3 2025, versus -$10.7 million for Q2 2025 and -$12.5 million for Q1 2025.